互补DNA
生物
ABCC1公司
基因
分子生物学
信使核糖核酸
多重耐药
ATP结合盒运输机
基因表达
复归
跨膜蛋白
基因剂量
癌细胞
运输机
遗传学
癌症
抗药性
受体
表型
作者
Susan P.C. Cole,Gabu Bhardwaj,James H. Gerlach,Jane E. Mackie,Caroline E. Grant,Kurt C. Almquist,Alistair Stewart,Ebba U. Kurz,Alessandra M.V. Duncan,R G Deeley
出处
期刊:Science
[American Association for the Advancement of Science (AAAS)]
日期:1992-12-04
卷期号:258 (5088): 1650-1654
被引量:3036
标识
DOI:10.1126/science.1360704
摘要
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
科研通智能强力驱动
Strongly Powered by AbleSci AI